Drug profile · INN
sodium monofluorophosphate
EXTRA-STRENGTH AIM
sodium monofluorophosphate (EXTRA-STRENGTH AIM) is an FDA-listed pharmaceutical active ingredient. Route of administration: dental. Current US regulatory status: approved.
Drug details — sodium monofluorophosphate
- US status
- approved
- Class
- —
- Route
- DENTAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
sodium monofluorophosphate (EXTRA-STRENGTH AIM) is an FDA-listed pharmaceutical active ingredient. Route of administration: dental. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is sodium monofluorophosphate?
sodium monofluorophosphate (EXTRA-STRENGTH AIM) is an FDA-listed pharmaceutical active ingredient. Route of administration: dental. Current US regulatory status: approved.
What is the brand name for sodium monofluorophosphate?
EXTRA-STRENGTH AIM is a marketed brand name for sodium monofluorophosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sodium monofluorophosphate?
sodium monofluorophosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.